Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06923293 · ClinicalTrials.gov registry record · NA
Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis
A NA study of Lower Limb Injury, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT06923293: Recruiting NA study of Lower Limb Injury, sponsored by Kessler Foundation.
NCT06923293 is a NA study of Lower Limb Injury that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 19 participants, below the 49-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06923293, a NA study of Lower Limb Injury, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to assess the ease, convenience, and efficacy of walking when using a motor powered ankle foot orthosis (AFO) brace, in adults who have had a lower limb injury.
Primary Outcome
10 meter walk test to evaluate walking speed after lower limb injury and in response to the intervention. Walking evaluated without versus with the motorized orthosis.
Conditions Studied
Interventions
- DEVICE Utilization of motorized orthosis
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT06923293 shows while recruiting
NCT06923293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 49-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Lower Limb Injury appearing as the primary indexed condition, and to 1 intervention - of which Utilization of motorized orthosis is the first listed.
NCT06923293 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06923293 about?
NCT06923293 is a clinical study titled "Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis". The purpose of this research study is to assess the ease, convenience, and efficacy of walking when using a motor powered ankle foot orthosis (AFO) brace, in adults who have had a lower limb injury.
What is the current status of trial NCT06923293?
This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2025-06-01. Estimated completion is 2027-06-01.
What conditions does trial NCT06923293 study?
This clinical trial studies the following conditions: Lower Limb Injury.
What interventions are being tested in trial NCT06923293?
The interventions under investigation include: Utilization of motorized orthosis (DEVICE).
Who is sponsoring clinical trial NCT06923293?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06923293 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Limb Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI